NLTX - Neoleukin Therapeutics Inc
IEX real time price
3.49
0.050 1.433%
Share volume: 25,485
Last Updated: Mon 18 Dec 2023 06:38:48 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$3.44
0.05
1.45%
Summary score
41%
Profitability
50%
Dept financing
20%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.01%
Return on assets
-7.62%
Return on sales
0%
Return on invested capital
1117.66%
Total debt ratio
7.39%
Debt ratio change over timeo
0.7%
Current Ratio
20.08%
Quick Ratio
0%
Cash Position Ratio
16%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-27%
Return on assets
-8.86%
Return on sales
0%
Return on invested capital
4248.28%
Total debt ratio
7.41%
Debt ratio change over timeo
5.51%
Current Ratio
25.57%
Quick Ratio
0%
Cash Position Ratio
25.39%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.57%
Return on assets
-6.72%
Return on sales
0%
Return on invested capital
-121.72%
Total debt ratio
11.44%
Debt ratio change over time
-1.1%
Current Ratio
20.73%
Quick Ratio
0%
Cash Position Ratio
20.65%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-3776.96%
Return on assets
-812.77%
Return on sales
0%
Return on invested capital
691973.86%
Total debt ratio
69.86%
Debt ratio change over time
0.7%
Current Ratio
1094.93%
Quick Ratio
0%
Cash Position Ratio
1079.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NLTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -13.01% | 0% | 0% | 29.06% |
| Return on assets | -7.62% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 1117.66% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 26% |
| Total debt ratio | 7.39% | 0% | 0% | 183.15% |
| Debt ratio change over time | 0.7% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 25.57% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 25.39% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 36% |
| Short-term ratios | NLTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -27% | 0% | 0% | -16.12% |
| Return on assets | -8.86% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 4248.28% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 1% |
| Total debt ratio | 7.41% | 0% | 0% | 79.61% |
| Debt ratio change over time | 5.51% | 0% | 0% | 0.09% |
| Dept financing | 27% | 0% | 0% | 25% |
| Current Ratio | 25.57% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 25.39% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 36% |